UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity

The Journal of pharmacology and experimental therapeutics, 2005-08, Vol.314 (2), p.652-660

2005

Volltextzugriff (PDF)

Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function

The Journal of pharmacology and experimental therapeutics, 2005-08, Vol.314 (2), p.643-651

2005

Volltextzugriff (PDF)

[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor

The Journal of pharmacology and experimental therapeutics, 2005-03, Vol.312 (3), p.1114

2005

Volltextzugriff (PDF)

Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)

Life sciences (1973), 1996-11, Vol.60 (1), p.PL15-PL21

1996

Volltextzugriff (PDF)

Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves

American journal of physiology. Regulatory, integrative and comparative physiology, 1999-10, Vol.277 (4), p.987-R995

1999

Volltextzugriff (PDF)

Nociceptin/Orphanin Fq Modulates The Cardiovascular, But Not Renal, Responses To Stress In Spontaneously Hypertensive Rats

Clinical and Experimental Pharmacology and Physiology, 2002-03, Vol.29 (3), p.254-259

2002

Volltextzugriff (PDF)

Central alpha 2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia

American journal of physiology. Regulatory, integrative and comparative physiology, 1998-12, Vol.275 (6), p.1867-R1874

1998

Volltextzugriff (PDF)

Differential Cardiovascular and Renal Responses Produced by Microinjection of the κ-Opioid U-50488H [( trans -3,4-Dichloro- N -methyl- N -[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) Methane Sulfonate] into Subregions of the Paraventricular Nucleus

The Journal of pharmacology and experimental therapeutics, 2005-02, Vol.312 (2), p.678-685

2005

Volltextzugriff (PDF)

Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats

The Journal of pharmacology and experimental therapeutics, 1999-04, Vol.289 (1), p.173

1999

Volltextzugriff (PDF)

Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus

The Journal of pharmacology and experimental therapeutics, 2005-02, Vol.312 (2), p.678

2005

Volltextzugriff (PDF)

Cardiovascular and renal responses produced by centra orphanin FQ/nociceptin occur independent of renal nerves

American journal of physiology. Regulatory, integrative and comparative physiology, 1999-10, Vol.46 (4), p.R987

1999

Volltextzugriff (PDF)

Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats

The Journal of pharmacology and experimental therapeutics, 1998-10, Vol.287 (1), p.238

1998

Volltextzugriff (PDF)

[(pF)Phe 4 ,Arg 14 ,Lys 15 ]N/OFQ-NH 2 (UFP-102), a Highly Potent and Selective Agonist of the Nociceptin/Orphanin FQ Receptor

The Journal of pharmacology and experimental therapeutics, 2005-03, Vol.312 (3), p.1114-1123

2005

Volltextzugriff (PDF)

Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia

American journal of physiology. Regulatory, integrative and comparative physiology, 1998-12, Vol.44 (6), p.R1867

1998

Volltextzugriff (PDF)

Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves

American journal of physiology. Regulatory, integrative and comparative physiology, 1999-10, Vol.277 (4), p.R987

1999

Volltextzugriff (PDF)

Central α 2 -receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia

American journal of physiology. Regulatory, integrative and comparative physiology, 1998-12, Vol.275 (6), p.R1867

1998

Volltextzugriff (PDF)

TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study

Pain reports, 2016-10, Vol.1 (4), p.e576-e576

2016

Volltextzugriff (PDF)

Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH 2)

Neuroscience letters, 1993-06, Vol.155 (2), p.220-222

1993

Volltextzugriff (PDF)

Chronic treatment with morphine and ethanol, but not cocaine, attenuates IL-1 beta activation of FOS expression in the rat hypothalamic paraventricular nucleus

Advances in experimental medicine and biology, 1995, Vol.373, p.201

1995

Volltextzugriff (PDF)

Pictrotoxin-induced seizures modified by morphine and opiate antagonists

Pharmacology, biochemistry and behavior, 1993, Vol.45 (3), p.615-617

1993

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity

Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function

[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor

Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)

Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves

Nociceptin/Orphanin Fq Modulates The Cardiovascular, But Not Renal, Responses To Stress In Spontaneously Hypertensive Rats

Central alpha 2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia

Differential Cardiovascular and Renal Responses Produced by Microinjection of the κ-Opioid U-50488H [( trans -3,4-Dichloro- N -methyl- N -[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) Methane Sulfonate] into Subregions of the Paraventricular Nucleus

Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats

Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus

Cardiovascular and renal responses produced by centra orphanin FQ/nociceptin occur independent of renal nerves

Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats

[(pF)Phe 4 ,Arg 14 ,Lys 15 ]N/OFQ-NH 2 (UFP-102), a Highly Potent and Selective Agonist of the Nociceptin/Orphanin FQ Receptor

Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia

Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves

Central α 2 -receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia

TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study

Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH 2)

Chronic treatment with morphine and ethanol, but not cocaine, attenuates IL-1 beta activation of FOS expression in the rat hypothalamic paraventricular nucleus

Pictrotoxin-induced seizures modified by morphine and opiate antagonists

Suchergebnisse filtern